4-Methylcyclohexane-1,2-dicarboxylic Anhydride (cis- and trans- mixture)>98.0%(GC)500g

Espátulas con forma de pala, 180 mm, 1 Pieza

(4-Bromophenyl)(thiophen-2-yl)methanone, 95.0%, 250mg

(S)-2-Amino-2-(3-fluorophenyl)ethanol, 95.0%, 25g

(R)-2-((2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide, 95.0%, 25mg

8-propyl-4-(pyridine-3-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Ethyl but-3-enoate (contains <30ppm MEHQ as inhibitor), 88.0%, 5g

(2-Chloro-pyrimidin-4-yl)-ethyl-amine, 95.0%, 1g

Sulfato de zinc heptahidrato/ / ACS 99,5+% 500 g

Methyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate, 95.0%, 1g

4-Bromo-N-methyl-3-methyl-2-nitroaniline, 95%, 25mg

4,5-Difluoro-2-methoxybenzonitrile, 97.0%, 5g

(3-Fluoro-2-hydroxyphenyl)boronic acid, 95.0%, 1g